US EditionPublished • loading... • Updated
EZH2 Directs HER2+ Breast Cancer Progression through the Modulation of Epithelial Plasticity
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
EZH2 Directs HER2+ Breast Cancer Progression through the Modulation of Epithelial Plasticity
To investigate the role of enhancer of zeste homolog 2 (EZH2) in HER2+ tumor progression, scientists crossed a genetically engineered mouse model of HER2-driven breast cancer with a conditional Ezh2 knockout strain. [EMBO Reports] Full ArticleGraphical Abstract
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
